BridgeBio Pharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,732 | $2,168 | $211,120 | $1,745 |
Gross Profit | 2,134 | 1,570 | 209,226 | 1,147 |
EBITDA | -139,655 | -51,033 | -11,093 | -148,475 |
EBIT | -141,193 | -52,607 | -12,689 | -150,060 |
Net Income | -162,040 | -73,456 | -35,216 | -168,148 |
Net Change In Cash | 2,732 | 2,168 | 211,120 | 1,745 |
Free Cash Flow | -182,298 | 72,256 | -221,029 | -125,254 |
Cash | 266,324 | 407,958 | 475,353 | 375,935 |
Basic Shares | 188,510 | 187,586 | 178,705 | 174,462 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $9,303 | $77,648 | $69,716 | $8,249 |
Gross Profit | 6,857 | 74,214 | 66,602 | 5,161 |
EBITDA | -565,468 | -397,443 | -533,833 | -465,745 |
EBIT | -571,962 | -404,214 | -539,676 | -468,833 |
Net Income | -643,202 | -493,964 | -639,297 | -483,925 |
Net Change In Cash | 9,303 | 77,648 | 69,716 | 8,249 |
Cost of Revenue | 20,519 | 37,686 | -5,518 | |
Free Cash Flow | -529,026 | -425,815 | -546,180 | -407,232 |
Cash | 375,935 | 376,689 | 393,772 | 356,082 |
Basic Shares | 162,791 | 147,473 | 144,356 | 117,995 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.85 |
2024-06-30 | -$0.39 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.96 |
